Pulse Biosciences, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Pulse Biosciences, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2021-09-30 was 0.00 shares.
- Pulse Biosciences, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2021-06-30 was 5.00K shares.
- Pulse Biosciences, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2021-03-31 was 39.98K shares.
- Pulse Biosciences, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2020-12-31 was 89.32K shares.
- Pulse Biosciences, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2020 was 175.07K shares, a 76.96% increase from fiscal 2019.
- Pulse Biosciences, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2019 was 98.93K shares, a 31.54% decline from fiscal 2018.
- Pulse Biosciences, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2018 was 144.51K shares, a 11.34% decline from fiscal 2017.
- Pulse Biosciences, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2017 was 162.99K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 12 month |
|---|---|---|
| 2021-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | 134.30K shares derived: sum of 4 quarters · filed 2021-11-15 |
| 2021-06-30 | 5.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | |
| 2021-03-31 | 39.98K shares 10-Q · filed 2021-05-10 | |
| 2020-12-31 | 89.32K shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-12 | 175.07K shares 10-K · filed 2021-03-12 |
| 2019-12-31 | 98.93K shares 10-K · filed 2020-03-16 | |
| 2018-12-31 | 144.51K shares 10-K · filed 2019-03-14 | |
| 2017-12-31 | 162.99K shares 10-K · filed 2018-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| iRhythm Holdings, Inc. (IRTC) | United States | $3.651B | -281.06 |
| ICU MEDICAL INC/DE (ICUI) | United States | $4.153B | 18.85 |
| Heartflow, Inc. (HTFL) | United States | $4.225B | |
| AtriCure, Inc. (ATRC) | United States | $3.089B | |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| NovoCure Ltd (NVCR) | $1.886B | -11.87 |